{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T22:32:45Z","timestamp":1786487565007,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":84,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100019265","name":"Yuhan Corporation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100019265","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2021R1A6A1A03038899"],"award-info":[{"award-number":["2021R1A6A1A03038899"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Korea Healthy Industry Development Institute","award":["RS-2023-KH135855"],"award-info":[{"award-number":["RS-2023-KH135855"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-53842-4","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T09:05:20Z","timestamp":1779267920000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Co-administration of calcium carbonate or sodium bicarbonate prevents esomeprazole-induced osteoporosis"],"prefix":"10.1038","volume":"16","author":[{"given":"Dae Hyun","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Hoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongju","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanhyeok","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da Bhin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye-Ryeong","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Ah","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungsin","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2825-3216","authenticated-orcid":false,"given":"Hang Lak","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3542-2276","authenticated-orcid":false,"given":"Tae-Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"53842_CR1","doi-asserted-by":"publisher","unstructured":"Lespessailles, E. & Toumi, H. Proton Pump Inhibitors and Bone Health: An Update Narrative Review. Int. J. Mol. Sci. 23 https:\/\/doi.org\/10.3390\/ijms231810733 (2022).","DOI":"10.3390\/ijms231810733"},{"key":"53842_CR2","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/nrgastro.2017.117","volume":"14","author":"P Malfertheiner","year":"2017","unstructured":"Malfertheiner, P., Kandulski, A. & Venerito, M. Proton-pump inhibitors: understanding the complications and risks. Nat. Rev. Gastroenterol. Hepatol. 14, 697\u2013710. https:\/\/doi.org\/10.1038\/nrgastro.2017.117 (2017).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"53842_CR3","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1001\/jama.2015.13766","volume":"314","author":"ED Kantor","year":"2015","unstructured":"Kantor, E. D., Rehm, C. D., Haas, J. S., Chan, A. T. & Giovannucci, E. L. Trends in Prescription Drug Use Among Adults in the United States From 1999\u20132012. JAMA 314, 1818\u20131831. https:\/\/doi.org\/10.1001\/jama.2015.13766 (2015).","journal-title":"JAMA"},{"key":"53842_CR4","doi-asserted-by":"publisher","unstructured":"Ito, T., Ramos-Alvarez, I. & Jensen, R. T. Long-Term Proton Pump Inhibitor-Acid Suppressive Treatment Can Cause Vitamin B(12) Deficiency in Zollinger-Ellison Syndrome (ZES) Patients. Int. J. Mol. Sci. 25 https:\/\/doi.org\/10.3390\/ijms25137286 (2024).","DOI":"10.3390\/ijms25137286"},{"key":"53842_CR5","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s00228-023-03534-z","volume":"79","author":"LGT Shanika","year":"2023","unstructured":"Shanika, L. G. T., Reynolds, A., Pattison, S. & Braund, R. Proton pump inhibitor use: systematic review of global trends and practices. Eur. J. Clin. Pharmacol. 79, 1159\u20131172. https:\/\/doi.org\/10.1007\/s00228-023-03534-z (2023).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"53842_CR6","doi-asserted-by":"publisher","first-page":"e56060","DOI":"10.1371\/journal.pone.0056060","volume":"8","author":"SR Rotman","year":"2013","unstructured":"Rotman, S. R. & Bishop, T. F. Proton pump inhibitor use in the U.S. ambulatory setting, 2002\u20132009. PLoS One. 8, e56060. https:\/\/doi.org\/10.1371\/journal.pone.0056060 (2013).","journal-title":"PLoS One"},{"key":"53842_CR7","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00406-014-0554-0","volume":"265","author":"B Haenisch","year":"2015","unstructured":"Haenisch, B. et al. Risk of dementia in elderly patients with the use of proton pump inhibitors. Eur. Arch. Psychiatry Clin. Neurosci. 265, 419\u2013428. https:\/\/doi.org\/10.1007\/s00406-014-0554-0 (2015).","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"53842_CR8","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1001\/jamainternmed.2015.7193","volume":"176","author":"B Lazarus","year":"2016","unstructured":"Lazarus, B. et al. Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease. JAMA Intern. Med. 176, 238\u2013246. https:\/\/doi.org\/10.1001\/jamainternmed.2015.7193 (2016).","journal-title":"JAMA Intern. Med."},{"key":"53842_CR9","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1046\/j.1365-2036.1996.d01-506.x","volume":"10","author":"SJ Lewis","year":"1996","unstructured":"Lewis, S. J., Franco, S., Young, G. & O\u2019Keefe, S. J. Altered bowel function and duodenal bacterial overgrowth in patients treated with omeprazole. Aliment. Pharmacol. Ther. 10, 557\u2013561. https:\/\/doi.org\/10.1046\/j.1365-2036.1996.d01-506.x (1996).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"53842_CR10","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1001\/jama.296.24.2947","volume":"296","author":"YX Yang","year":"2006","unstructured":"Yang, Y. X., Lewis, J. D., Epstein, S. & Metz, D. C. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA 296, 2947\u20132953. https:\/\/doi.org\/10.1001\/jama.296.24.2947 (2006).","journal-title":"JAMA"},{"key":"53842_CR11","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s00198-010-1337-8","volume":"22","author":"S Pouwels","year":"2011","unstructured":"Pouwels, S. et al. Use of proton pump inhibitors and risk of hip\/femur fracture: a population-based case-control study. Osteoporos. Int. 22, 903\u2013910. https:\/\/doi.org\/10.1007\/s00198-010-1337-8 (2011).","journal-title":"Osteoporos. Int."},{"key":"53842_CR12","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00223-014-9855-6","volume":"94","author":"J Ding","year":"2014","unstructured":"Ding, J., Heller, D. A., Ahern, F. M. & Brown, T. V. The relationship between proton pump inhibitor adherence and fracture risk in the elderly. Calcif Tissue Int. 94, 597\u2013607. https:\/\/doi.org\/10.1007\/s00223-014-9855-6 (2014).","journal-title":"Calcif Tissue Int."},{"key":"53842_CR13","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1007\/s00198-015-3168-0","volume":"26","author":"DE Freedberg","year":"2015","unstructured":"Freedberg, D. E. et al. Use of proton pump inhibitors is associated with fractures in young adults: a population-based study. Osteoporos. Int. 26, 2501\u20132507. https:\/\/doi.org\/10.1007\/s00198-015-3168-0 (2015).","journal-title":"Osteoporos. Int."},{"key":"53842_CR14","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1002\/jbmr.2279","volume":"29","author":"JR Lewis","year":"2014","unstructured":"Lewis, J. R. et al. Long-term proton pump inhibitor therapy and falls and fractures in elderly women: a prospective cohort study. J. Bone Min. Res. 29, 2489\u20132497. https:\/\/doi.org\/10.1002\/jbmr.2279 (2014).","journal-title":"J. Bone Min. Res."},{"key":"53842_CR15","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.bone.2015.08.024","volume":"81","author":"MMC van der Hoorn","year":"2015","unstructured":"van der Hoorn, M. M. C., Tett, S. E., de Vries, O. J., Dobson, A. J. & Peeters, G. The effect of dose and type of proton pump inhibitor use on risk of fractures and osteoporosis treatment in older Australian women: A prospective cohort study. Bone 81, 675\u2013682. https:\/\/doi.org\/10.1016\/j.bone.2015.08.024 (2015).","journal-title":"Bone"},{"key":"53842_CR16","doi-asserted-by":"publisher","unstructured":"Bioletto, F. et al. Sex-specific Association of Chronic Proton Pump Inhibitor Use With Reduced Bone Density and Quality. J. Clin. Endocrinol. Metab. 110 https:\/\/doi.org\/10.1210\/clinem\/dgae598 (2025). e2071-e2079.","DOI":"10.1210\/clinem\/dgae598"},{"key":"53842_CR17","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1111\/1756-185X.12866","volume":"19","author":"A Arj","year":"2016","unstructured":"Arj, A. et al. Proton pump inhibitors use and change in bone mineral density. Int. J. Rheum. Dis. 19, 864\u2013868. https:\/\/doi.org\/10.1111\/1756-185X.12866 (2016).","journal-title":"Int. J. Rheum. Dis."},{"key":"53842_CR18","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1007\/s00296-013-2709-0","volume":"33","author":"K Ozdil","year":"2013","unstructured":"Ozdil, K. et al. Bone density in proton pump inhibitors users: a prospective study. Rheumatol. Int. 33, 2255\u20132260. https:\/\/doi.org\/10.1007\/s00296-013-2709-0 (2013).","journal-title":"Rheumatol. Int."},{"key":"53842_CR19","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1517\/14656566.6.14.2501","volume":"6","author":"D Castell","year":"2005","unstructured":"Castell, D. Review of immediate-release omeprazole for the treatment of gastric acid-related disorders. Expert Opin. Pharmacother. 6, 2501\u20132510. https:\/\/doi.org\/10.1517\/14656566.6.14.2501 (2005).","journal-title":"Expert Opin. Pharmacother"},{"key":"53842_CR20","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s00228-008-0538-y","volume":"64","author":"S Shi","year":"2008","unstructured":"Shi, S. & Klotz, U. Proton pump inhibitors: an update of their clinical use and pharmacokinetics. Eur. J. Clin. Pharmacol. 64, 935\u2013951. https:\/\/doi.org\/10.1007\/s00228-008-0538-y (2008).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"53842_CR21","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.2147\/DDDT.S212491","volume":"13","author":"D Kim","year":"2019","unstructured":"Kim, D. et al. The safety, pharmacodynamics, and pharmacokinetics of immediate-release formulation containing esomeprazole 20\u00a0mg\/sodium bicarbonate 800\u00a0mg in healthy adult male. Drug Des. Devel Ther. 13, 3151\u20133159. https:\/\/doi.org\/10.2147\/DDDT.S212491 (2019).","journal-title":"Drug Des. Devel Ther."},{"key":"53842_CR22","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1056\/NEJM199009273231305","volume":"323","author":"B Dawson-Hughes","year":"1990","unstructured":"Dawson-Hughes, B. et al. A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. N Engl. J. Med. 323, 878\u2013883. https:\/\/doi.org\/10.1056\/NEJM199009273231305 (1990).","journal-title":"N Engl. J. Med."},{"key":"53842_CR23","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0002-9343(99)80310-6","volume":"98","author":"IR Reid","year":"1995","unstructured":"Reid, I. R., Ames, R. W., Evans, M. C., Gamble, G. D. & Sharpe, S. J. Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: a randomized controlled trial. Am. J. Med. 98, 331\u2013335. https:\/\/doi.org\/10.1016\/S0002-9343(99)80310-6 (1995).","journal-title":"Am. J. Med."},{"key":"53842_CR24","doi-asserted-by":"publisher","first-page":"243","DOI":"10.4078\/jrd.2023.0024","volume":"30","author":"S Jo","year":"2023","unstructured":"Jo, S. et al. Elevated BMPR2 expression amplifies osteoblast differentiation in ankylosing spondylitis. J. Rheum. Dis. 30, 243\u2013250. https:\/\/doi.org\/10.4078\/jrd.2023.0024 (2023).","journal-title":"J. Rheum. Dis."},{"key":"53842_CR25","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1572-0241.2003.07186.x","volume":"98","author":"BC Jacobson","year":"2003","unstructured":"Jacobson, B. C. et al. Who is using chronic acid suppression therapy and why? Am. J. Gastroenterol. 98, 51\u201358. https:\/\/doi.org\/10.1111\/j.1572-0241.2003.07186.x (2003).","journal-title":"Am. J. Gastroenterol."},{"key":"53842_CR26","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1503\/cmaj.071330","volume":"179","author":"LE Targownik","year":"2008","unstructured":"Targownik, L. E. et al. Use of proton pump inhibitors and risk of osteoporosis-related fractures. CMAJ 179, 319\u2013326. https:\/\/doi.org\/10.1503\/cmaj.071330 (2008).","journal-title":"CMAJ"},{"key":"53842_CR27","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00198-018-4788-y","volume":"30","author":"TN Poly","year":"2019","unstructured":"Poly, T. N., Islam, M. M., Yang, H. C., Wu, C. C. & Li, Y. J. Proton pump inhibitors and risk of hip fracture: a meta-analysis of observational studies. Osteoporos. Int. 30, 103\u2013114. https:\/\/doi.org\/10.1007\/s00198-018-4788-y (2019).","journal-title":"Osteoporos. Int."},{"key":"53842_CR28","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.amjmed.2005.02.007","volume":"118","author":"MB O\u2019Connell","year":"2005","unstructured":"O\u2019Connell, M. B., Madden, D. M., Murray, A. M., Heaney, R. P. & Kerzner, L. J. Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial. Am. J. Med. 118, 778\u2013781. https:\/\/doi.org\/10.1016\/j.amjmed.2005.02.007 (2005).","journal-title":"Am. J. Med."},{"key":"53842_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.therap.2020.06.019","volume":"76","author":"A Koyyada","year":"2021","unstructured":"Koyyada, A. Long-term use of proton pump inhibitors as a risk factor for various adverse manifestations. Therapie 76, 13\u201321. https:\/\/doi.org\/10.1016\/j.therap.2020.06.019 (2021).","journal-title":"Therapie"},{"key":"53842_CR30","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00198-015-3386-5","volume":"27","author":"CM Weaver","year":"2016","unstructured":"Weaver, C. M. et al. Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation. Osteoporos. Int. 27, 367\u2013376. https:\/\/doi.org\/10.1007\/s00198-015-3386-5 (2016).","journal-title":"Osteoporos. Int."},{"key":"53842_CR31","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/jcp.21767","volume":"220","author":"W Geng","year":"2009","unstructured":"Geng, W. et al. Inhibition of osteoclast formation and function by bicarbonate: role of soluble adenylyl cyclase. J. Cell. Physiol. 220, 332\u2013340. https:\/\/doi.org\/10.1002\/jcp.21767 (2009).","journal-title":"J. Cell. Physiol."},{"key":"53842_CR32","doi-asserted-by":"publisher","first-page":"2594664","DOI":"10.1155\/2023\/2594664","volume":"2023","author":"F Saki","year":"2023","unstructured":"Saki, F., Shams, M., Dastghaib, S. & Koohpeyma, F. Pantoprazole-Induced Bone Loss through Gastrin Secretion: A Stereological Study. Biomed. Res. Int. 2023, 2594664. https:\/\/doi.org\/10.1155\/2023\/2594664 (2023).","journal-title":"Biomed. Res. Int."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53842-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53842-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53842-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T22:26:28Z","timestamp":1786487188000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53842-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["53842"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-53842-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"10 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experimental procedures were performed in accordance with the Guide for the Care and Use of Laboratory Animals and were approved by the Animal Ethics Screening Committee of Hanyang University (2025\u20130089\u00a0A).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dae Hyun Lim, Seung Hoon Lee, Dongju Kim, Chanhyeok Jeon, Da Bhin Kim, Hye-Ryeong Jo, Jin Ah Shin, Sungsin Jo, and Tae-Hwan Kim declare they have no financial interests. Hang Lak Lee has received research support from Yuhan Corporation.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"24949"}}